Jack Regan, PhD: “We’ve never developed a vaccine against coronavirus. And because of that, the question is how efficacious is this vaccine going to be? How long is the immunity going to last?”
Jack Regan, PhD, wants to stress that he would like to see a vaccine for coronavirus disease 2019 (COVID-19) as much as anybody. And even though Regan is the CEO and founder of LexaGene, a company that manufactures COVID-19 tests, he thinks that testing will be a huge part of trying to contain the coronavirus, vaccine or no vaccine. However, as with everything COVID, the science is in flux. He cites recent studies of some COVID patients whose antibodies against peak at a certain point, and then wane. If the COVID antibodies don’t stay sustained for a long period of time, someone “could literally get either exposed or vaccinated and get sick again, literally two or three months later, which is very, very troubling. We should not be looking at this winter with the vaccine coming as the end of the pandemic.”
CDC HICPAC Considers New Airborne Pathogen Guidelines Amid Growing Concerns
November 18th 2024The CDC HICPAC discussed updates to airborne pathogen guidelines, emphasizing the need for masks in health care. Despite risks, the committee resisted universal masking, highlighting other mitigation strategies
The Importance of Hand Hygiene in Clostridioides difficile Reduction
November 18th 2024Clostridioides difficile infections burden US healthcare. Electronic Hand Hygiene Monitoring (EHHMS) systems remind for soap and water. This study evaluates EHHMS effectiveness by comparing C difficile cases in 10 hospitals with CMS data, linking EHHMS use to reduced cases.
Breaking the Cycle: Long COVID's Impact and the Urgent Need for Preventative Measures
November 15th 2024Masking, clean air, and vaccinations are essential in combating COVID-19 and preventing long-term impacts, as evidence mounts of long COVID's significant economic, cognitive, and behavioral effects.
Our Understanding of Immune Issues Is Evolving: Here Are 5 Reasons Why
October 25th 2024The past 5 years in medicine have seen significant advances in RNA vaccines, understanding immune dysregulation, and improved interspecialty communication, promising better disease eradication and tailored treatments.